Research Article
Investigation of the Clinical Significance and Prognostic Value of the lncRNA ACVR2B-As1 in Liver Cancer
Table 3
Univariate and multivariate analysis of overall survival in patients with liver cancer.
| Parameters | Univariate analysis | Multivariate analysis | Hazard ratio | 95%CI (lower∼upper) | value | Hazard ratio | 95% CI (lower-upper) | value |
| Age | 1.02 | 0.7–1.48 | 0.926 | | | | Gender | 0.82 | 0.57–1.16 | 0.263 | | | | Histological type | 0.98 | 0.27–3.63 | 0.982 | | | | Histologic grade | 1.05 | 0.85–1.31 | 0.651 | | | | Stage | 1.38 | 1.15–1.65 | 0.001 | 0.90 | 0.72–1.11 | 0.325 | T Classification | 1.65 | 1.38–1.98 | ≤0.001 | 1.72 | 1.36–2.16 | ≤0.001 | N classification | 0.71 | 0.5–1.03 | 0.071 | | | | M Classification | 0.70 | 0.48–1.02 | 0.061 | | | | Radiation therapy | 0.52 | 0.26–1.03 | 0.061 | | | | Residual tumor | 1.42 | 1.12–1.79 | 0.004 | 1.46 | 1.14–1.87 | 0.003 | ACVR2B-AS1 | 2.03 | 1.4–2.94 | ≤0.001 | 1.90 | 1.31–2.76 | 0.001 |
|
|